Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
AMZN$271.31+5.28(+1.98%)Global Delivery Drones Market by Payload, Range, MTOW, Platform, Application, and Region - Forecast to 2031 | Healthcare and Hybrid Drones Fuel 21.6% CAGR to $7.65 Billion9:23:39 AM ETAMD$451.23-37.55(-7.68%)Heterogeneous Computing Market Size and Share - Industry Trends and Growth Forecasts (2026-2031) | Generative AI and Cloud Adoption Fuel 21.87% CAGR9:20:42 AM ETAMD$451.23-37.55(-7.68%)Global Accelerated Computing Market Size, Share, Industry Trends, and Growth Forecasts, 2026-2031 | AI Training and Edge Inference Fuel 20.19% CAGR and Custom Silicon Opportunities9:19:40 AM ETFISI$40.44+1.09(+2.77%)Virtual Desktop Infrastructure (VDI) Endpoint Market Size, Share, Trends, and Forecast 2026-2031 | Hybrid Work and Zero Trust Drive 14.48% CAGR Toward USD 9.89 Billion9:18:45 AM ETMSFT$555.76-0.04(-0.01%)Carbon-Aware Computing Platform Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | AI Demand and ESG Mandates Propel Market to USD 2.95 Billion9:17:39 AM ETSOLV$89.56+0.21(+0.24%)UAE Hospital Supplies Market Size and Share Analysis, Industry Trends, and Growth Forecasts, 2026-2031 | AI Procurement and Infection-Control Demand Fuel 8.10% CAGR9:11:38 AM ETACN$268.20+3.93(+1.49%)Application Outsourcing - Market Size, Share, Industry Trends, and Growth Forecasts, 2026-2031 | Cloud, AI, and Security Demand Drive Market to USD 215.46 Billion9:10:49 AM ETCSCO$100.38-3.28(-3.16%)Desktop Virtualization Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | Cloud DaaS and Hybrid Work Propel Market to USD 20.54 Billion as Asia-Pacific Leads Growth9:09:39 AM ETIBM$255.55+1.23(+0.48%)Industrial Edge Computing Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | Edge AI, IIoT, and Private-5G Drive 13.24% CAGR to USD 114.87 Billion9:08:39 AM ETQUBT$6.22-0.21(-3.27%)Next-generation Computing Market Size, Share, Trends, and Growth Forecasts 2026-2031 | AI, Quantum, and Edge Investment Drive 19.02% CAGR to USD 650.48 Billion9:07:40 AM ETDIS$119.95+1.00(+0.84%)I've Been Writing About Disney Stock for 30 Years. Here's Why My Conviction Has Never Been Higher.9:07:00 AM ETKO$96.82+0.94(+0.98%)Digital Transformation (DX) - Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | AI and Cloud Adoption Drive Growth to USD 5.33 Trillion9:05:41 AM ETMSFT$555.76-0.04(-0.01%)Not One Analyst Rates Microsoft a Sell. Is the Consensus View Right?9:05:39 AM ETLLY$1,433.97+15.83(+1.12%)Prediction: The Weight-Loss Drug Boom Could Be Just the Beginning for Lilly9:03:54 AM ETBNTX$90.62-0.02(-0.02%)Messenger Ribonucleic Acid (mRNA) Manufacturing Service Market Report 2026 | Capitalize on 16.2% CAGR in IVT and LNP with Thermo Fisher, Merck, Lonza and GenScript ProBio9:03:39 AM ETMSFT$555.76-0.04(-0.01%)Green IT Software Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | ESG Mandates and AI Optimization Propel Market to USD 49.35 Billion9:02:40 AM ETAMZN$271.31+5.28(+1.98%)CEO Andy Jassy Just Told Investors That AWS Can Grow Revenue 40% in 2027 and 2028 and Eventually Become a Trillion-Dollar Business. Is It Enough to Get Wall Street on Board?9:02:00 AM ETTEM$73.01-2.61(-3.45%)Personal Genome Services Market Report 2026: Global Forecast to 2030 | Market to Reach $13.69 Billion by 2030 as Personalized Medicine Adoption Accelerates9:01:40 AM ETVZ$46.68+0.51(+1.10%)Verizon announces cap increases and expiration and results of its tender offers for five series of notes9:00:57 AM ETJPM$358.02+5.80(+1.65%)Chase Travel Unveils 27 Trips to Take in 2027 and Previews Expanded Luxury Vacation Homes Offering9:00:16 AM ETAMGN$481.21+2.73(+0.57%)REPATHA® LOWERS RISK OF HEART ATTACKS BY 20% COMPARED WITH EZETIMIBE IN A LARGE REAL-WORLD STUDY9:00:00 AM ETTM$216.00+16.54(+8.29%)Forterra and May Mobility Advance to Phase III of DIU’s ROADS Challenge, Bringing Autonomous Rides to Soldiers on Military Bases9:00:00 AM ETTXN$301.50-10.10(-3.24%)XGIMI and Kickstarter Present NYC Innovation Showcase Featuring Record-Breaking AURA 3 Series Projector9:00:00 AM ETTM$216.00+16.54(+8.29%)2027 Toyota RAV4 Builds on a Fully Electrified Formula with New Woodland Capability and Expanded Charging Convenience9:00:00 AM ET

NTHI · NASDAQ

Neonc Technologies Holdings, Inc.

$3.07 -0.13 (-4.06%)

Company overview

Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that has completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Market cap
$88.4M
Employees
8
Headquarters
Calabasas, CA
Website
neonctech.com
CEO
Amir Farrokh Heshmatpour
Listed
March 26, 2025
P/E
-1.58
Dividend yield
0.00%

Company financials

Revenue
$0.00
Gross profit
-$31,980
Operating income
-$33.4M
EBITDA
-$34.6M
Net income
-$38.6M
EPS
-$1.94
Total assets
$3.3M
Total debt
$346,053
Earnings yield
-63.19%

Price chart

2.333.504.675.847.01
NTHI 1D NASDAQ O3.15H3.20L3.03C3.20+0.13 (+4.23%)Vol43.65K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
View
Ticker Type Headline Source Published
NTHINeonc Technologies Holdings, Inc. Press release NeOnc Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress GlobeNewswire
NTHINeonc Technologies Holdings, Inc. Press release Four Elevated Short Interest Stocks as Oil Retreats and Midterm Elections Approach GlobeNewswire
NTHINeonc Technologies Holdings, Inc. Press release NeOnc Is Putting Two Brain Cancer Programs on the Global Stage GlobeNewswire
NTHINeonc Technologies Holdings, Inc. Press release NeOnc Technologies to Present Data from Its NEO100 and NEO212 Programs at the 31st Annual Meeting of the Society for Neuro-Oncology GlobeNewswire
NTHINeonc Technologies Holdings, Inc. Press release NeOnc’s Ambitious Brain Cancer Plans are Setting the Stage GlobeNewswire
NTHINeonc Technologies Holdings, Inc. Press release 2027 Could Finally Be the Year Cancer Is on the Ropes! GlobeNewswire
NTHINeonc Technologies Holdings, Inc. Press release Defining Moments in the Race for Biotech Breakthroughs GlobeNewswire
NTHINeonc Technologies Holdings, Inc. Press release NeOnc Targets Major Brain Cancer Trial Expansion with 500 Patients Across 30 Hospitals in Three Countries GlobeNewswire
NTHINeonc Technologies Holdings, Inc. Press release NeOnc Breaks Through Key Levels, as Brain-Cancer Stock’s Catalysts Continue GlobeNewswire
NTHINeonc Technologies Holdings, Inc. Press release Healthcare Stocks Rushing Higher, with Oncology Push, Breakout Test, and Lilly’s Next Growth Chapter GlobeNewswire
NTHINeonc Technologies Holdings, Inc. Press release NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight GlobeNewswire
NTHINeonc Technologies Holdings, Inc. Press release NeOnc Technologies to Be Featured on Health Uncensored with Dr. Drew to Discuss Reaching Brain Tumors Without Surgery or Systemic Chemotherapy GlobeNewswire
NTHINeonc Technologies Holdings, Inc. Press release Brain Cancer Research: The Race for Better CNS Cancer Treatments Could Open a Multibillion-Dollar Market GlobeNewswire
NTHINeonc Technologies Holdings, Inc. Press release NeOnc's Brain Cancer Efforts Bring Hope as FDA Meeting Approaches Newsfile
NTHINeonc Technologies Holdings, Inc. Press release NeOnc Deepens Abu Dhabi Research Ties as Its Brain Cancer Story Moves Forward GlobeNewswire
NTHINeonc Technologies Holdings, Inc. Press release NeOnc Technologies and the Department of Health – Abu Dhabi Sign MoU to Advance Brain Cancer Research and Proposed Clinical Collaboration GlobeNewswire
NTHINeonc Technologies Holdings, Inc. Press release Forget the Ugly Sweaters and Ugly Charts, NeOnc is Ready for Catalyst Season GlobeNewswire
NTHINeonc Technologies Holdings, Inc. Press release NeOnc's Most Challenging Test Yet: Compassionate-Use Update Puts NEO100's Potential in Focus Newsfile
NTHINeonc Technologies Holdings, Inc. Press release NeOnc’s Boldest Test Yet: Child’s Early Improvement Puts NEO100 in the Spotlight with Compassionate-Use Milestone GlobeNewswire
NTHINeonc Technologies Holdings, Inc. Press release NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi GlobeNewswire
See more
FAQ

Questions about Neonc Technologies Holdings, Inc.

What does Neonc Technologies Holdings, Inc. do?
Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that has completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.
What is NTHI's market cap?
Neonc Technologies Holdings, Inc. (NTHI) is a listed stock with a live quote. The latest market cap on this page is $88.4M.
Where is Neonc Technologies Holdings, Inc. headquartered?
Neonc Technologies Holdings, Inc. is headquartered in Calabasas, CA.
How do I get NTHI news from the API?
Call GET /v1/news?tickers=NTHI. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does NTHI news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for NTHI, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the NTHI price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs